nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—SLC6A2—Diethylpropion—obesity	0.163	0.194	CbGbCtD
Bretylium—SLC6A2—Phendimetrazine—obesity	0.124	0.147	CbGbCtD
Bretylium—SLC6A2—Sibutramine—obesity	0.124	0.147	CbGbCtD
Bretylium—SLC6A2—Benzphetamine—obesity	0.0936	0.111	CbGbCtD
Bretylium—SLC6A2—Phentermine—obesity	0.0936	0.111	CbGbCtD
Bretylium—SLC6A2—Phenylpropanolamine—obesity	0.0893	0.106	CbGbCtD
Bretylium—SLC6A2—Bupropion—obesity	0.0796	0.0947	CbGbCtD
Bretylium—SLC6A2—Methamphetamine—obesity	0.0748	0.089	CbGbCtD
Bretylium—SLC6A2—sympathetic nervous system—obesity	0.00927	0.245	CbGeAlD
Bretylium—SLC6A2—autonomic nervous system—obesity	0.00623	0.164	CbGeAlD
Bretylium—Rash macular—Sibutramine—obesity	0.00306	0.0298	CcSEcCtD
Bretylium—ATP1A1—hindbrain—obesity	0.00295	0.078	CbGeAlD
Bretylium—ATP1A1—gall bladder—obesity	0.00291	0.0769	CbGeAlD
Bretylium—Psychotic disorder—Methamphetamine—obesity	0.0028	0.0273	CcSEcCtD
Bretylium—Psychotic disorder—Benzphetamine—obesity	0.0027	0.0263	CcSEcCtD
Bretylium—Edrophonium—BCHE—obesity	0.00247	1	CrCbGaD
Bretylium—Psychotic disorder—Phendimetrazine—obesity	0.00247	0.024	CcSEcCtD
Bretylium—Psychotic disorder—Phenylpropanolamine—obesity	0.00211	0.0205	CcSEcCtD
Bretylium—ATP1A1—Preimplantation Embryo—TFAP2B—obesity	0.00209	0.13	CbGpPWpGaD
Bretylium—Psychotic disorder—Phentermine—obesity	0.00202	0.0196	CcSEcCtD
Bretylium—ATP1A1—islet of Langerhans—obesity	0.00191	0.0504	CbGeAlD
Bretylium—ATP1A1—respiratory system—obesity	0.0018	0.0476	CbGeAlD
Bretylium—Psychotic disorder—Diethylpropion—obesity	0.00175	0.0171	CcSEcCtD
Bretylium—Angina pectoris—Phentermine—obesity	0.00174	0.0169	CcSEcCtD
Bretylium—Rash macular—Topiramate—obesity	0.0017	0.0166	CcSEcCtD
Bretylium—Psychotic disorder—Cimetidine—obesity	0.00167	0.0162	CcSEcCtD
Bretylium—Flushing—Phendimetrazine—obesity	0.00162	0.0158	CcSEcCtD
Bretylium—Paranoia—Bupropion—obesity	0.00161	0.0156	CcSEcCtD
Bretylium—SLC6A2—respiratory system—obesity	0.0016	0.0423	CbGeAlD
Bretylium—ATP1A1—adrenal cortex—obesity	0.00151	0.04	CbGeAlD
Bretylium—Sweating increased—Diethylpropion—obesity	0.00151	0.0147	CcSEcCtD
Bretylium—Ventricular extrasystoles—Sibutramine—obesity	0.00139	0.0135	CcSEcCtD
Bretylium—Flushing—Phenylpropanolamine—obesity	0.00138	0.0135	CcSEcCtD
Bretylium—ATP1A1—cardiovascular system—obesity	0.00138	0.0365	CbGeAlD
Bretylium—Hyperhidrosis—Benzphetamine—obesity	0.00132	0.0128	CcSEcCtD
Bretylium—ATP1A1—pituitary gland—obesity	0.00122	0.0323	CbGeAlD
Bretylium—ATP1A1—adipose tissue—obesity	0.00122	0.0322	CbGeAlD
Bretylium—Bradycardia—Cimetidine—obesity	0.0012	0.0117	CcSEcCtD
Bretylium—Hyperhidrosis—Phendimetrazine—obesity	0.0012	0.0117	CcSEcCtD
Bretylium—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A14—obesity	0.00116	0.0722	CbGpPWpGaD
Bretylium—ATP1A1—digestive system—obesity	0.00115	0.0303	CbGeAlD
Bretylium—Anxiety—Phenylpropanolamine—obesity	0.0011	0.0107	CcSEcCtD
Bretylium—ATP1A1—adrenal gland—obesity	0.00109	0.0289	CbGeAlD
Bretylium—Hypertension—Phentermine—obesity	0.00107	0.0104	CcSEcCtD
Bretylium—Confusional state—Phenylpropanolamine—obesity	0.00107	0.0104	CcSEcCtD
Bretylium—Paranoia—Topiramate—obesity	0.00102	0.00997	CcSEcCtD
Bretylium—Nasal congestion—Sibutramine—obesity	0.001	0.00975	CcSEcCtD
Bretylium—Abdominal pain—Phendimetrazine—obesity	0.000981	0.00954	CcSEcCtD
Bretylium—SLC6A2—adrenal gland—obesity	0.000971	0.0256	CbGeAlD
Bretylium—Diarrhoea—Methamphetamine—obesity	0.000966	0.0094	CcSEcCtD
Bretylium—ATP1A1—endocrine gland—obesity	0.000948	0.025	CbGeAlD
Bretylium—Dyspnoea—Phenylpropanolamine—obesity	0.000945	0.00919	CcSEcCtD
Bretylium—Dizziness—Methamphetamine—obesity	0.000933	0.00908	CcSEcCtD
Bretylium—Diarrhoea—Benzphetamine—obesity	0.000931	0.00906	CcSEcCtD
Bretylium—Anxiety—Diethylpropion—obesity	0.000917	0.00892	CcSEcCtD
Bretylium—Dizziness—Benzphetamine—obesity	0.0009	0.00876	CcSEcCtD
Bretylium—Affect lability—Sibutramine—obesity	0.000898	0.00874	CcSEcCtD
Bretylium—Psychotic disorder—Sibutramine—obesity	0.000891	0.00867	CcSEcCtD
Bretylium—Nasal congestion—Bupropion—obesity	0.000873	0.0085	CcSEcCtD
Bretylium—Feeling abnormal—Phenylpropanolamine—obesity	0.000873	0.0085	CcSEcCtD
Bretylium—Anxiety—Cimetidine—obesity	0.000873	0.00849	CcSEcCtD
Bretylium—Mood swings—Sibutramine—obesity	0.000864	0.00841	CcSEcCtD
Bretylium—ATP1A1—liver—obesity	0.000854	0.0226	CbGeAlD
Bretylium—Hyperhidrosis—Diethylpropion—obesity	0.000853	0.0083	CcSEcCtD
Bretylium—Diarrhoea—Phendimetrazine—obesity	0.000849	0.00826	CcSEcCtD
Bretylium—Confusional state—Cimetidine—obesity	0.000846	0.00823	CcSEcCtD
Bretylium—SLC6A2—endocrine gland—obesity	0.000842	0.0222	CbGeAlD
Bretylium—Orthostatic hypotension—Sibutramine—obesity	0.000833	0.00811	CcSEcCtD
Bretylium—Dizziness—Phendimetrazine—obesity	0.00082	0.00798	CcSEcCtD
Bretylium—Lethargy—Bupropion—obesity	0.000812	0.0079	CcSEcCtD
Bretylium—Nausea—Benzphetamine—obesity	0.000808	0.00787	CcSEcCtD
Bretylium—SLC6A2—Amine compound SLC transporters—SLC6A14—obesity	0.000806	0.0501	CbGpPWpGaD
Bretylium—Abdominal pain—Phentermine—obesity	0.000802	0.0078	CcSEcCtD
Bretylium—Sweating increased—Orlistat—obesity	0.000794	0.00772	CcSEcCtD
Bretylium—Dyspnoea—Diethylpropion—obesity	0.000787	0.00765	CcSEcCtD
Bretylium—Affect lability—Bupropion—obesity	0.000783	0.00762	CcSEcCtD
Bretylium—Psychotic disorder—Bupropion—obesity	0.000777	0.00756	CcSEcCtD
Bretylium—Angina pectoris—Sibutramine—obesity	0.000768	0.00747	CcSEcCtD
Bretylium—Mood swings—Bupropion—obesity	0.000754	0.00733	CcSEcCtD
Bretylium—Nausea—Phendimetrazine—obesity	0.000737	0.00717	CcSEcCtD
Bretylium—Feeling abnormal—Diethylpropion—obesity	0.000727	0.00707	CcSEcCtD
Bretylium—Orthostatic hypotension—Bupropion—obesity	0.000727	0.00707	CcSEcCtD
Bretylium—Dizziness—Phenylpropanolamine—obesity	0.000701	0.00682	CcSEcCtD
Bretylium—Diarrhoea—Phentermine—obesity	0.000694	0.00675	CcSEcCtD
Bretylium—Feeling abnormal—Cimetidine—obesity	0.000692	0.00673	CcSEcCtD
Bretylium—Conjunctivitis—Sibutramine—obesity	0.000684	0.00665	CcSEcCtD
Bretylium—Vomiting—Phenylpropanolamine—obesity	0.000674	0.00656	CcSEcCtD
Bretylium—Dizziness—Phentermine—obesity	0.000671	0.00652	CcSEcCtD
Bretylium—Sweating increased—Bupropion—obesity	0.00067	0.00652	CcSEcCtD
Bretylium—Body temperature increased—Cimetidine—obesity	0.000664	0.00646	CcSEcCtD
Bretylium—Vomiting—Phentermine—obesity	0.000645	0.00627	CcSEcCtD
Bretylium—Bradycardia—Sibutramine—obesity	0.000643	0.00625	CcSEcCtD
Bretylium—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC22A1—obesity	0.000637	0.0396	CbGpPWpGaD
Bretylium—Nausea—Phenylpropanolamine—obesity	0.000629	0.00612	CcSEcCtD
Bretylium—Diarrhoea—Diethylpropion—obesity	0.000604	0.00587	CcSEcCtD
Bretylium—Nausea—Phentermine—obesity	0.000602	0.00586	CcSEcCtD
Bretylium—Conjunctivitis—Bupropion—obesity	0.000596	0.0058	CcSEcCtD
Bretylium—Dizziness—Diethylpropion—obesity	0.000583	0.00568	CcSEcCtD
Bretylium—Diarrhoea—Cimetidine—obesity	0.000574	0.00559	CcSEcCtD
Bretylium—Vomiting—Diethylpropion—obesity	0.000561	0.00546	CcSEcCtD
Bretylium—Nasal congestion—Topiramate—obesity	0.000556	0.00541	CcSEcCtD
Bretylium—Dizziness—Cimetidine—obesity	0.000555	0.0054	CcSEcCtD
Bretylium—Vomiting—Cimetidine—obesity	0.000534	0.00519	CcSEcCtD
Bretylium—Nausea—Diethylpropion—obesity	0.000524	0.0051	CcSEcCtD
Bretylium—Lethargy—Topiramate—obesity	0.000517	0.00503	CcSEcCtD
Bretylium—Flushing—Bupropion—obesity	0.000511	0.00497	CcSEcCtD
Bretylium—Vertigo—Orlistat—obesity	0.00051	0.00496	CcSEcCtD
Bretylium—ATP1A1—Ion channel transport—GABRA6—obesity	0.000505	0.0314	CbGpPWpGaD
Bretylium—Affect lability—Topiramate—obesity	0.000499	0.00485	CcSEcCtD
Bretylium—Nausea—Cimetidine—obesity	0.000499	0.00485	CcSEcCtD
Bretylium—Psychotic disorder—Topiramate—obesity	0.000495	0.00482	CcSEcCtD
Bretylium—Vertigo—Sibutramine—obesity	0.000494	0.0048	CcSEcCtD
Bretylium—Syncope—Sibutramine—obesity	0.000493	0.00479	CcSEcCtD
Bretylium—Loss of consciousness—Sibutramine—obesity	0.000483	0.0047	CcSEcCtD
Bretylium—Anxiety—Orlistat—obesity	0.000482	0.00469	CcSEcCtD
Bretylium—Mood swings—Topiramate—obesity	0.00048	0.00467	CcSEcCtD
Bretylium—Hypertension—Sibutramine—obesity	0.000474	0.00462	CcSEcCtD
Bretylium—Anxiety—Sibutramine—obesity	0.000466	0.00454	CcSEcCtD
Bretylium—Orthostatic hypotension—Topiramate—obesity	0.000463	0.0045	CcSEcCtD
Bretylium—Confusional state—Sibutramine—obesity	0.000452	0.0044	CcSEcCtD
Bretylium—Hyperhidrosis—Orlistat—obesity	0.000448	0.00436	CcSEcCtD
Bretylium—SLC6A2—Amine compound SLC transporters—SLC22A1—obesity	0.000442	0.0275	CbGpPWpGaD
Bretylium—Shock—Sibutramine—obesity	0.000441	0.00429	CcSEcCtD
Bretylium—Hyperhidrosis—Sibutramine—obesity	0.000434	0.00422	CcSEcCtD
Bretylium—Vertigo—Bupropion—obesity	0.00043	0.00419	CcSEcCtD
Bretylium—Syncope—Bupropion—obesity	0.00043	0.00418	CcSEcCtD
Bretylium—Angina pectoris—Topiramate—obesity	0.000427	0.00415	CcSEcCtD
Bretylium—Sweating increased—Topiramate—obesity	0.000427	0.00415	CcSEcCtD
Bretylium—Loss of consciousness—Bupropion—obesity	0.000421	0.0041	CcSEcCtD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A7—obesity	0.000416	0.0259	CbGpPWpGaD
Bretylium—Hypertension—Bupropion—obesity	0.000414	0.00402	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—TNFRSF11B—obesity	0.000409	0.0254	CbGpPWpGaD
Bretylium—Anxiety—Bupropion—obesity	0.000406	0.00395	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—HRH3—obesity	0.000402	0.025	CbGpPWpGaD
Bretylium—Dyspnoea—Sibutramine—obesity	0.0004	0.00389	CcSEcCtD
Bretylium—Confusional state—Bupropion—obesity	0.000394	0.00384	CcSEcCtD
Bretylium—Shock—Bupropion—obesity	0.000385	0.00374	CcSEcCtD
Bretylium—Feeling abnormal—Orlistat—obesity	0.000382	0.00372	CcSEcCtD
Bretylium—Conjunctivitis—Topiramate—obesity	0.00038	0.00369	CcSEcCtD
Bretylium—Gastrointestinal pain—Orlistat—obesity	0.000379	0.00369	CcSEcCtD
Bretylium—Hyperhidrosis—Bupropion—obesity	0.000378	0.00368	CcSEcCtD
Bretylium—Feeling abnormal—Sibutramine—obesity	0.00037	0.0036	CcSEcCtD
Bretylium—Gastrointestinal pain—Sibutramine—obesity	0.000367	0.00357	CcSEcCtD
Bretylium—Abdominal pain—Orlistat—obesity	0.000366	0.00356	CcSEcCtD
Bretylium—Body temperature increased—Orlistat—obesity	0.000366	0.00356	CcSEcCtD
Bretylium—Bradycardia—Topiramate—obesity	0.000357	0.00347	CcSEcCtD
Bretylium—Abdominal pain—Sibutramine—obesity	0.000355	0.00345	CcSEcCtD
Bretylium—Body temperature increased—Sibutramine—obesity	0.000355	0.00345	CcSEcCtD
Bretylium—Dyspnoea—Bupropion—obesity	0.000349	0.00339	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—SLC6A4—obesity	0.000327	0.0203	CbGpPWpGaD
Bretylium—Flushing—Topiramate—obesity	0.000325	0.00317	CcSEcCtD
Bretylium—Feeling abnormal—Bupropion—obesity	0.000322	0.00313	CcSEcCtD
Bretylium—Gastrointestinal pain—Bupropion—obesity	0.00032	0.00311	CcSEcCtD
Bretylium—Diarrhoea—Orlistat—obesity	0.000317	0.00309	CcSEcCtD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A14—obesity	0.000315	0.0196	CbGpPWpGaD
Bretylium—ATP1A1—Ion channel transport—TRPV1—obesity	0.000312	0.0194	CbGpPWpGaD
Bretylium—Abdominal pain—Bupropion—obesity	0.000309	0.00301	CcSEcCtD
Bretylium—Body temperature increased—Bupropion—obesity	0.000309	0.00301	CcSEcCtD
Bretylium—Diarrhoea—Sibutramine—obesity	0.000307	0.00299	CcSEcCtD
Bretylium—Dizziness—Orlistat—obesity	0.000306	0.00298	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—CES1—obesity	0.0003	0.0186	CbGpPWpGaD
Bretylium—Dizziness—Sibutramine—obesity	0.000297	0.00289	CcSEcCtD
Bretylium—Vomiting—Orlistat—obesity	0.000295	0.00287	CcSEcCtD
Bretylium—SLC6A2—Monoamine Transport—NOS1—obesity	0.000291	0.0181	CbGpPWpGaD
Bretylium—Vomiting—Sibutramine—obesity	0.000285	0.00277	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—ME1—obesity	0.000279	0.0173	CbGpPWpGaD
Bretylium—Nausea—Orlistat—obesity	0.000275	0.00268	CcSEcCtD
Bretylium—Vertigo—Topiramate—obesity	0.000274	0.00267	CcSEcCtD
Bretylium—Syncope—Topiramate—obesity	0.000274	0.00266	CcSEcCtD
Bretylium—Loss of consciousness—Topiramate—obesity	0.000268	0.00261	CcSEcCtD
Bretylium—Diarrhoea—Bupropion—obesity	0.000268	0.0026	CcSEcCtD
Bretylium—Nausea—Sibutramine—obesity	0.000266	0.00259	CcSEcCtD
Bretylium—Hypertension—Topiramate—obesity	0.000264	0.00256	CcSEcCtD
Bretylium—Anxiety—Topiramate—obesity	0.000259	0.00252	CcSEcCtD
Bretylium—Dizziness—Bupropion—obesity	0.000259	0.00252	CcSEcCtD
Bretylium—Confusional state—Topiramate—obesity	0.000251	0.00244	CcSEcCtD
Bretylium—Vomiting—Bupropion—obesity	0.000249	0.00242	CcSEcCtD
Bretylium—Shock—Topiramate—obesity	0.000245	0.00238	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—AQP7—obesity	0.000243	0.0151	CbGpPWpGaD
Bretylium—Hyperhidrosis—Topiramate—obesity	0.000241	0.00234	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—FTL—obesity	0.000237	0.0147	CbGpPWpGaD
Bretylium—Nausea—Bupropion—obesity	0.000232	0.00226	CcSEcCtD
Bretylium—SLC6A2—NRF2 pathway—SLC6A14—obesity	0.000227	0.0141	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC16A7—obesity	0.000222	0.0138	CbGpPWpGaD
Bretylium—Dyspnoea—Topiramate—obesity	0.000222	0.00216	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—LCN2—obesity	0.000207	0.0128	CbGpPWpGaD
Bretylium—Feeling abnormal—Topiramate—obesity	0.000205	0.002	CcSEcCtD
Bretylium—Gastrointestinal pain—Topiramate—obesity	0.000204	0.00198	CcSEcCtD
Bretylium—Abdominal pain—Topiramate—obesity	0.000197	0.00192	CcSEcCtD
Bretylium—Body temperature increased—Topiramate—obesity	0.000197	0.00192	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—COX7C—obesity	0.000194	0.0121	CbGpPWpGaD
Bretylium—SLC6A2—Monoamine Transport—AGT—obesity	0.00019	0.0118	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC16A7—obesity	0.000189	0.0118	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—PPARD—obesity	0.000176	0.0109	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—FTL—obesity	0.000176	0.0109	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—GABRA6—obesity	0.000176	0.0109	CbGpPWpGaD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A1—obesity	0.000173	0.0107	CbGpPWpGaD
Bretylium—Diarrhoea—Topiramate—obesity	0.00017	0.00166	CcSEcCtD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC6A14—obesity	0.000168	0.0105	CbGpPWpGaD
Bretylium—Dizziness—Topiramate—obesity	0.000165	0.0016	CcSEcCtD
Bretylium—Vomiting—Topiramate—obesity	0.000158	0.00154	CcSEcCtD
Bretylium—Nausea—Topiramate—obesity	0.000148	0.00144	CcSEcCtD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC6A14—obesity	0.000143	0.00891	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—G6PD—obesity	0.000143	0.00888	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC9A3—obesity	0.000139	0.00867	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—HK2—obesity	0.000133	0.00827	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC27A1—obesity	0.000128	0.00793	CbGpPWpGaD
Bretylium—SLC6A2—Monoamine Transport—IL1B—obesity	0.000119	0.00739	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC9A3—obesity	0.000119	0.00738	CbGpPWpGaD
Bretylium—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—obesity	0.000117	0.00726	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GPX3—obesity	0.000116	0.0072	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—HK2—obesity	0.000113	0.00704	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC27A1—obesity	0.000109	0.00675	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—TRPV1—obesity	0.000108	0.00674	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—AQP7—obesity	0.000105	0.00653	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—HK1—obesity	0.000104	0.00649	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—SLC6A4—obesity	9.71e-05	0.00603	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC16A7—obesity	9.61e-05	0.00597	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC22A1—obesity	9.22e-05	0.00573	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—LCN2—obesity	8.93e-05	0.00555	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—HK1—obesity	8.89e-05	0.00553	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—NQO1—obesity	8.78e-05	0.00546	CbGpPWpGaD
Bretylium—SLC6A2—Monoamine Transport—TNF—obesity	8.62e-05	0.00536	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—PRKAR2B—obesity	8.51e-05	0.00529	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—SLC2A4—obesity	8.42e-05	0.00523	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—COX7C—obesity	8.4e-05	0.00522	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—GGT1—obesity	8.15e-05	0.00507	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—GCK—obesity	8.01e-05	0.00498	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC22A1—obesity	7.85e-05	0.00488	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—CETP—obesity	7.73e-05	0.0048	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—TF—obesity	7.64e-05	0.00475	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—GABRA6—obesity	7.6e-05	0.00472	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—FTL—obesity	7.6e-05	0.00472	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—TFRC—obesity	7.33e-05	0.00455	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC6A14—obesity	7.28e-05	0.00453	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—HMOX1—obesity	7.22e-05	0.00449	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—GCK—obesity	6.82e-05	0.00424	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—SLC2A4—obesity	6.23e-05	0.00387	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—CYCS—obesity	6.15e-05	0.00382	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC9A3—obesity	6.03e-05	0.00375	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—NCOA1—obesity	5.94e-05	0.00369	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—PLG—obesity	5.79e-05	0.0036	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—HK2—obesity	5.76e-05	0.00358	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC27A1—obesity	5.52e-05	0.00343	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—GNB3—obesity	5.37e-05	0.00334	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—HMOX1—obesity	5.35e-05	0.00332	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—SLC2A4—obesity	5.3e-05	0.0033	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—GNAS—obesity	5.23e-05	0.00325	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—APOB—obesity	5.12e-05	0.00318	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—TRPV1—obesity	4.69e-05	0.00292	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—HK1—obesity	4.52e-05	0.00281	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—PPARA—obesity	4.32e-05	0.00268	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—APOA1—obesity	4.05e-05	0.00252	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC22A1—obesity	3.99e-05	0.00248	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—PRKAR2B—obesity	3.68e-05	0.00229	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—GCK—obesity	3.47e-05	0.00215	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—CETP—obesity	3.34e-05	0.00208	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—TF—obesity	3.31e-05	0.00206	CbGpPWpGaD
Bretylium—ATP1A1—Transmembrane transport of small molecules—ALB—obesity	3.21e-05	0.002	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—TFRC—obesity	3.17e-05	0.00197	CbGpPWpGaD
Bretylium—SLC6A2—NRF2 pathway—TGFB1—obesity	2.74e-05	0.0017	CbGpPWpGaD
Bretylium—SLC6A2—SLC-mediated transmembrane transport—ALB—obesity	2.73e-05	0.0017	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—SLC2A4—obesity	2.7e-05	0.00168	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—CYCS—obesity	2.66e-05	0.00165	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—NCOA1—obesity	2.57e-05	0.0016	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—PLG—obesity	2.51e-05	0.00156	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—GNB3—obesity	2.32e-05	0.00144	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—HMOX1—obesity	2.31e-05	0.00144	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—GNAS—obesity	2.26e-05	0.00141	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—APOB—obesity	2.21e-05	0.00138	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—PPARA—obesity	1.87e-05	0.00116	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—APOA1—obesity	1.75e-05	0.00109	CbGpPWpGaD
Bretylium—SLC6A2—Transmembrane transport of small molecules—ALB—obesity	1.39e-05	0.000863	CbGpPWpGaD
